where you get that batch of that product available to the entire population for the elementnts of patien so it may imply some bad, proof of variableles, and then commercial use and medical use at a wide scale, because you have the prediction. you need to have the p predictin minutes that are ready to produce. claire: we heard in the report -- jan-cedric: not just the mutation, which is also the case. claire: i am sorry, carry on. all ririt, so we will move on.n. oftendricic: that wass also the case in disaster medicine or a situation like that. claire: sorry about the delay. jan-cedric: go ahead. claire: i was saying in the report, there are four experimental ebola drugs being tested in the drc. what can you tell us about the other two, and is itfour different labs? jan-cedric: yes, it is four different labs, one being the with just public, but the others are private companies, and the two others were already tested in 2014, eight ebola strain in west africa. and they were so far the best of obvususly, theyey werere used asas controls durire present clinical stutudy, and bebeing outnumbe